002437 誉衡药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.10212.8867.308-16.5272.408
总资产报酬率 ROA (%)2.1137.7883.330-6.6440.978
投入资产回报率 ROIC (%)2.96110.5484.311-8.5251.291

边际利润分析
销售毛利率 (%)48.91053.46058.38956.92557.528
营业利润率 (%)12.53011.6716.666-8.6903.049
息税前利润/营业总收入 (%)12.55011.5797.924-7.1735.000
净利润/营业总收入 (%)11.2359.9374.901-9.3151.712

收益指标分析
经营活动净收益/利润总额(%)83.69078.23277.354-22.98754.757
价值变动净收益/利润总额(%)5.433-3.077-23.40499.959-10.831
营业外收支净额/利润总额(%)-0.173-0.4090.979-0.151-11.540

偿债能力分析
流动比率 (X)1.0611.0660.8180.7770.822
速动比率 (X)0.8530.8370.6830.6860.690
资产负债率 (%)31.97230.16745.74958.18757.852
带息债务/全部投入资本 (%)4.6091.62029.48547.66147.104
股东权益/带息债务 (%)2,039.8255,981.618234.766107.551110.091
股东权益/负债合计 (%)210.186228.885115.22368.81069.737
利息保障倍数 (X)297.267-264.7006.646-4.7692.206

营运能力分析
应收账款周转天数 (天)18.92924.34629.73726.27331.902
存货周转天数 (天)59.84260.11166.68276.13197.426